Oncotarget · 2015 · 44 citations · 28 references
These results reveal that GSK-3β regulates mTOR/p70S6K1 signaling pathway and inhibits glioma progression in vivo; its inactivation via p-GSK-3β (Ser9) is associated with glioma development, which is new mechanism that may be helpful in developing GSK-3β-based treatment of glioma in the future.
28
Radiotherapy plus Concomitant and Adjuvant Temozolomide for Glioblastoma
Roger Stupp, Warren Mason, Martin J. van den Bent et al. · New England Journal of Medicine · 2005 · 21K citations · Full text
Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas
Michael Walker, Eben Alexander, William E. Hunt et al. · Journal of neurosurgery · 1978 · 1.7K citations